Mohammad Ali Akbarzadeh1, Isa Khaheshi2, Amirsina Sharifi3, Negin Yousefi1, Mohammadreza Naderian4, Mohammad Hasan Namazi1, Morteza Safi1, Hossein Vakili1, Habibollah Saadat1, Saeed Alipour Parsa1, Negin Nickdoost1. 1. Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Modarres Hospital, Kaj square, Sa'adat Abad Ave, Tehran 1998734383, Iran. 2. Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Modarres Hospital, Kaj square, Sa'adat Abad Ave, Tehran 1998734383, Iran. Electronic address: isa.khaheshi@gmail.com. 3. Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran. 4. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran; Cardiac Outcome Research and Education (CORE), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Abstract
BACKGROUND: Unfavorable associations between air pollution and myocardial infarction are broadly investigated in recent studies and some of them revealed considerable associations; however, controversies exists between these investigations with regard to culprit components of air pollution and significance of correlation between myocardial infarction risk and air pollution. METHODS: The association between exposure to PM10, PM2.5, ozone, carbon monoxide, sulfur dioxide, and nitrogen dioxide concentration of background air that residents of Tehran, the capital city of Iran, which is ranked as the most air polluted city of Iran and the relative risk of developing ST-elevation myocardial infarction (STEMI) were investigated by a case-crossover design. Our study included 208 patients admitted with a diagnosis of STEMI and undergone primary percutaneous intervention. Air pollutant concentration was averaged in 24-h windows preceding the time of onset of myocardial infarction for the case period. Besides, the mean level of each element of air pollution of the corresponding time in one week, two weeks and three weeks before onset of myocardial infarction, was averaged separately for each day as one control periods. Thus, 624 control periods were included in our investigation such that. Each patient is matched and compared with him/herself. RESULTS: The mean level of PM10 in case periods (61.47µg/m3) was significantly higher than its level in control periods (57.86µg/m3) (P-value = 0.019, 95% CI: 1.002-1.018, RR = 1.010). Also, the mean level of PM2.5 in case periods (95.40µg/m3) was significantly higher than that in control days (90.88µg/m3) (P-value = 0.044, 95% CI: 1.001-1.011, RR = 1.006). The level of other components including NO2, SO2, CO and O3 showed no significant differences between case and control periods. A 10µg/m3 increase in PM10 and PM2.5 would result in 10.10% and 10.06% increase in STEMI event, respectively. Furthermore, the results of sub-group analysis showed that older patients (equal or more than 60 year-old), diabetic patients, non-hypertensive ones and patients with more than one diseased vessel may be more vulnerable to the harmful effect of particular matters including PM10 and PM2.5 on development of STEMI. CONCLUSION: Air pollution is a worldwide pandemic with great potential to cause terrible events especially cardiovascular ones. PM2.5 and PM10 are amongst ambient air pollutant with a high risk of developing STEMI. Thus, more restrictive legislations should be applied to define a safe level of indoor and outdoor air pollutant production.
BACKGROUND: Unfavorable associations between air pollution and myocardial infarction are broadly investigated in recent studies and some of them revealed considerable associations; however, controversies exists between these investigations with regard to culprit components of air pollution and significance of correlation between myocardial infarction risk and air pollution. METHODS: The association between exposure to PM10, PM2.5, ozone, carbon monoxide, sulfur dioxide, and nitrogen dioxide concentration of background air that residents of Tehran, the capital city of Iran, which is ranked as the most air polluted city of Iran and the relative risk of developing ST-elevation myocardial infarction (STEMI) were investigated by a case-crossover design. Our study included 208 patients admitted with a diagnosis of STEMI and undergone primary percutaneous intervention. Air pollutant concentration was averaged in 24-h windows preceding the time of onset of myocardial infarction for the case period. Besides, the mean level of each element of air pollution of the corresponding time in one week, two weeks and three weeks before onset of myocardial infarction, was averaged separately for each day as one control periods. Thus, 624 control periods were included in our investigation such that. Each patient is matched and compared with him/herself. RESULTS: The mean level of PM10 in case periods (61.47µg/m3) was significantly higher than its level in control periods (57.86µg/m3) (P-value = 0.019, 95% CI: 1.002-1.018, RR = 1.010). Also, the mean level of PM2.5 in case periods (95.40µg/m3) was significantly higher than that in control days (90.88µg/m3) (P-value = 0.044, 95% CI: 1.001-1.011, RR = 1.006). The level of other components including NO2, SO2, CO and O3 showed no significant differences between case and control periods. A 10µg/m3 increase in PM10 and PM2.5 would result in 10.10% and 10.06% increase in STEMI event, respectively. Furthermore, the results of sub-group analysis showed that older patients (equal or more than 60 year-old), diabeticpatients, non-hypertensive ones and patients with more than one diseased vessel may be more vulnerable to the harmful effect of particular matters including PM10 and PM2.5 on development of STEMI. CONCLUSION: Air pollution is a worldwide pandemic with great potential to cause terrible events especially cardiovascular ones. PM2.5 and PM10 are amongst ambient air pollutant with a high risk of developing STEMI. Thus, more restrictive legislations should be applied to define a safe level of indoor and outdoor air pollutant production.
Authors: Christopher Zuidema; Larissa V Stebounova; Sinan Sousan; Geb Thomas; Kirsten Koehler; Thomas M Peters Journal: J Occup Environ Hyg Date: 2019-06-28 Impact factor: 2.155
Authors: Javad Torkashvand; Ahamd Jonidi Jafari; Philip K Hopke; Abbas Shahsavani; Mostafa Hadei; Majid Kermani Journal: J Environ Health Sci Eng Date: 2021-01-07
Authors: Andrew Fu Wah Ho; Huili Zheng; Arul Earnest; Kang Hao Cheong; Pin Pin Pek; Jeon Young Seok; Nan Liu; Yu Heng Kwan; Jack Wei Chieh Tan; Ting Hway Wong; Derek J Hausenloy; Ling Li Foo; Benjamin Yong Qiang Tan; Marcus Eng Hock Ong Journal: J Am Heart Assoc Date: 2019-03-19 Impact factor: 5.501
Authors: David M Stieb; Carine Zheng; Dina Salama; Rania Berjawi; Monica Emode; Robyn Hocking; Ninon Lyrette; Carlyn Matz; Eric Lavigne; Hwashin H Shin Journal: Environ Health Date: 2020-05-01 Impact factor: 5.984
Authors: Meng Wang; Philip K Hopke; Mauro Masiol; Sally W Thurston; Scott Cameron; Frederick Ling; Edwin van Wijngaarden; Daniel Croft; Stefania Squizzato; Kelly Thevenet-Morrison; David Chalupa; David Q Rich Journal: Environ Health Date: 2019-09-06 Impact factor: 5.984
Authors: Francesca Gorini; Kyriazoula Chatzianagnostou; Annamaria Mazzone; Elisa Bustaffa; Augusto Esposito; Sergio Berti; Fabrizio Bianchi; Cristina Vassalle Journal: Int J Environ Res Public Health Date: 2020-10-09 Impact factor: 3.390